The association between the +61 G/A polymorphism of the epidermal growth factor (EGF) gene and glioma risk remains controversial and unclear. The objective of this study was to investigate the association between the EGF +61 G/A polymorphism and glioma risk in a Chinese Han population. Peripheral blood samples were extracted from 160 glioma patients and 320 control subjects. Genotyping was performed using a polymerase chain reaction–restriction fragment length polymorphism method. Glioma patients had a significantly higher frequency of the AA genotype (odds ratio [OR] 1.93, 95% confidence intervals [CI] 1.08, 3.44) than control subjects and the frequency of the AA genotype was significantly higher in glioblastoma patients than in patients with other gliomas (OR 2.19, 95% CI 1.05, 4.57). Patients with grade IV gliomas had a significantly higher frequency of the AA genotype (OR 2.25, 95% CI 1.08, 4.71) than patients with lower grade gliomas. This study demonstrated that the EGF +61 AA genotype is associated with an increased risk of glioma in a Chinese Han population.
YanHParsonsDWJinG: IDH1 and IDH2 mutations in gliomas. N Engl J Med2009; 360: 765–773.
2.
ThurnherMM: 2007 World Health Organization classification of tumours of the central nervous system. Cancer Imaging2009; 9 (Spec No A): S1–S3.
3.
FullerGNScheithauerBW: The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: Newly codified entities. Brain Pathol2007; 17: 304–307.
4.
ZhouXDWangXYQuFJ: Detection of cancer stem cells from the C6 glioma cell line. J Int Med Res2009; 37: 503–510.
5.
WangJLiuXHouWH: The relationship between intra-operative ultrasonography and pathological grade in cerebral glioma. J Int Med Res2008; 36: 1426–1434.
6.
WenPYKesariS: Malignant gliomas in adults. N Engl J Med2008; 359: 492–507.
7.
StuppRMasonWPvan den BentMJ: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med2005; 352: 987–996.
8.
TsitlakidisAForoglouNVenetisCA: Biopsy versus resection in the management of malignant gliomas: A systematic review and meta-analysis. J Neurosurg2010; 112: 1020–1032.
9.
SalomonDSBrandtRCiardielloF: Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol1995; 19: 183–232.
10.
CohenS: Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem1962; 237: 1555–1562.
11.
MortonCCByersMGNakaiH: Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22–q24.1, 11p15, and 4q25–q27, respectively. Cytogenet Cell Genet1986; 41: 245–249.
12.
ShahbaziMPravicaVNasreenN: Association between functional polymorphism in EGF gene and malignant melanoma. Lancet2002; 359: 397–401.
13.
JinGMiaoRDengY: Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci2007; 98: 864–868.
14.
ZhangYMCaoCLiangK: Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: A meta-analysis. Cancer Epidemiol2010; 34: 150–156.
15.
LanutiMLiuGGoodwinJM: A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res2008; 14: 3216–3222.
16.
LimYJKimJWSongJY: Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett2005; 374: 157–160.
17.
KangHGChoiJELeeWK: +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology2007; 12: 902–905.
18.
VishnoiMPandeySNModiDR: Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor β1 −509C>T gene polymorphisms with gallbladder cancer. Hum Immunol2008; 69: 360–367.
19.
SpindlerKLNielsenJNOrnskovD: Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer. Acta Oncol2007; 46: 1113–1117.
20.
KangSKimJWParkNH: Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer. Int J Gynecol Cancer2007; 17: 492–496.
21.
BhowmickDAZhuangZWaitSD: A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res2004; 64: 1220–1223.
22.
CostaBMFerreiraPCostaS: Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res2007; 13: 2621–2626.
23.
VauleonEAugerNBenouaich-AmielA: The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet2007; 172: 33–37.
24.
LiuXLiLChenX: No association between EGF +61 A/G polymorphism and increased risk of glioma. Int J Biol Markers2009; 24: 77–82.
25.
PintoGRYoshiokaFKClaraCA: Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil. Int J Biol Markers2009; 24: 277–281.
26.
WangSZhaoYRuanZ: Association between EGF +61 G/A and glioma risk in a Chinese population. BMC Cancer2010; 10: 221.
27.
TanabeKKLemoineAFinkelsteinDM: Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA2008; 299: 53–60.
28.
PastoreSMasciaFMarianiV: The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol2008; 128: 1365–1374.
ZhangZKimuraMItokawaY: The decrement of carcinogenesis by dietary selenium and expression of placental form of glutathione-S-transferase in rat glioma. Biol Trace Elem Res1997; 57: 147–155.
31.
JanikPSzaniawskaBKowalczykD: The effect of phorbol ester treatment on migration of C3H 10T1/2 and BT5C glioma cells: Possible application to carcinogenesis. J Cancer Res Clin Oncol1994; 120: 156–158.
32.
RooneyAGvan NieuwenhuizenDReijneveldJC: Female gender is not a proven risk factor for depression in glioma. J Neurooncol2009; 95: 449.
33.
HoubenMPLouwmanWJTijssenCC: Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients. Ann Oncol2004; 15: 1256–1260.
34.
HockingB: Occupational exposure to ionizing and non-ionizing radiation and risk of glioma. Occup Med (Lond)2008; 58: 148–149; author reply 149.
35.
KaripidisKKBenkeGSimMR: Occupational exposure to ionizing and non-ionizing radiation and risk of glioma. Occup Med (Lond)2007; 57: 518–524.
36.
RonEModanBBoiceJD: Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med1988; 319: 1033–1039.
37.
HolickCNGiovannucciELRosnerB: Prospective study of cigarette smoking and adult glioma: Dosage, duration, and latency. Neuro Oncol2007; 9: 326–334.
38.
SilveraSAMillerABRohanTE: Cigarette smoking and risk of glioma: A prospective cohort study. Int J Cancer2006; 118: 1848–1851.
39.
ZhengTCantorKPZhangY: Risk of brain glioma not associated with cigarette smoking or use of other tobacco products in Iowa. Cancer Epidemiol Biomarkers Prev2001; 10: 413–414.
40.
HurleySFMcNeilJJDonnanGA: Tobacco smoking and alcohol consumption as risk factors for glioma: A case–control study in Melbourne, Australia. J Epidemiol Community Health1996; 50: 442–446.
41.
EfirdJTFriedmanGDSidneyS: The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: Cigarette smoking and other lifestyle behaviors. J Neurooncol2004; 68: 57–69.
